People · Operator

Clifford A. Reid

Named in public records as an officer, director or promoter · active 2009–2021 · Biotechnology

2
Companies
6
Filings
$27.7M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Complete Genomics IncBiotechnologySeries A$14.5M$523.8M2009
Travera, LLCBiotechnologySeries A$13.3M$89.2M2018
Operator network

Clifford A. Reid at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Charles P. Waite, Jr. · 4 companies · 1 sharedCharles P. Waite,…Alexander E. Barkas, Ph.D. · 1 companies · 1 sharedAlexander E. Bark…Andrew Senyei, M.D. · 1 companies · 1 sharedAndrew Senyei, M.…Robert J. Curson · 1 companies · 1 sharedRobert J. CursonL. Robert Johnson · 5 companies · 1 sharedL. Robert JohnsonDavid A. Margulies · 1 companies · 1 sharedDavid A. MarguliesDavid Robert Margulies · 1 companies · 1 sharedDavid Robert Marg…Laurence Robert Johnson · 1 companies · 1 sharedLaurence Robert J…L. Robert A. Johnson · 1 companies · 1 sharedL. Robert A. John…Patrick A. Zhang · 1 companies · 1 sharedPatrick A. ZhangPatrick Robert Zhang · 1 companies · 1 sharedPatrick Robert Zh…Complete Genomics Inc · $14.5M raisedComplete Genomics IncTravera, LLC · $13.3M raisedTravera, LLCClifford A. ReidCR
Clifford A. Reid Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Clifford A. Reid on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
L. Robert Johnson15
Charles P. Waite, Jr.14
David Robert Margulies11
Patrick Robert Zhang11
David A. Margulies11
Patrick A. Zhang11
L. Robert A. Johnson11
Alexander E. Barkas, Ph.D.11
Robert J. Curson11
Andrew Senyei, M.D.11
Laurence Robert Johnson11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.